RHPN2 Drives Mesenchymal Transformation in Malignant Glioma by Triggering RhoA Activation

被引:51
作者
Danussi, Carla [1 ]
Akavia, Uri David [2 ,6 ]
Niola, Francesco [1 ]
Jovic, Andreja [6 ]
Lasorella, Anna [1 ,3 ,4 ]
Pe'er, Dana [2 ,6 ]
Iavarone, Antonio [1 ,4 ,5 ]
机构
[1] Columbia Univ, Inst Canc Genet, Med Ctr, New York, NY 10032 USA
[2] Columbia Univ, Dept Syst Biol, Med Ctr, New York, NY 10032 USA
[3] Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10032 USA
[4] Columbia Univ, Dept Pathol, Med Ctr, New York, NY 10032 USA
[5] Columbia Univ, Dept Neurol, Med Ctr, New York, NY 10032 USA
[6] Columbia Univ, Dept Biol Sci, New York, NY 10032 USA
关键词
GLIOBLASTOMA; CANCER; PROTEIN; GTPASES; PHOSPHORYLATION; DIFFERENTIATION; RHOPHILIN-2; MIGRATION; INVASION; NETWORK;
D O I
10.1158/0008-5472.CAN-13-1168-T
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Mesenchymal transformation is a hallmark of aggressive glioblastoma (GBM). Here, we report the development of an unbiased method for computational integration of copy number variation, expression, and mutation data from large datasets. Using this method, we identified rhophilin 2 (RHPN2) as a central genetic determinant of the mesenchymal phenotype of human GBM. Notably, amplification of the human RHPN2 gene on chromosome 19 correlates with a dramatic decrease in the survival of patients with glioma. Ectopic expression of RHPN2 in neural stem cells and astrocytes triggered the expression of mesenchymal genes and promoted an invasive phenotype without impacting cell proliferation. Mechanistically, these effects were implemented through RHPN2-mediated activation of RhoA, a master regulator of cell migration and invasion. Our results define RHPN2 amplification as a central genetic determinant of a highly aggressive phenotype that directs the worst clinical outcomes in patients with GBM. (C) 2013 AACR.
引用
收藏
页码:5140 / 5150
页数:11
相关论文
共 35 条
[1]
Genetic regulators of large-scale transcriptional signatures in cancer [J].
Adler, AS ;
Lin, MH ;
Horlings, H ;
Nuyten, DSA ;
van de Vijver, MJ ;
Chang, HY .
NATURE GENETICS, 2006, 38 (04) :421-430
[2]
An Integrated Approach to Uncover Drivers of Cancer [J].
Akavia, Uri David ;
Litvin, Oren ;
Kim, Jessica ;
Sanchez-Garcia, Felix ;
Kotliar, Dylan ;
Causton, Helen C. ;
Pochanard, Panisa ;
Mozes, Eyal ;
Garraway, Levi A. ;
Pe'er, Dana .
CELL, 2010, 143 (06) :1005-1017
[3]
The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma [J].
Bhat, Krishna P. L. ;
Salazar, Katrina L. ;
Balasubramaniyan, Veerakumar ;
Wani, Khalida ;
Heathcock, Lindsey ;
Hollingsworth, Faith ;
James, Johanna D. ;
Gumin, Joy ;
Diefes, Kristin L. ;
Kim, Se Hoon ;
Turski, Alice ;
Azodi, Yasaman ;
Yang, Yuhui ;
Doucette, Tiffany ;
Colman, Howard ;
Sulman, Erik P. ;
Lang, Frederick F. ;
Rao, Ganesh ;
Copray, Sjef ;
Vaillant, Brian D. ;
Aldape, Kenneth D. .
GENES & DEVELOPMENT, 2011, 25 (24) :2594-2609
[4]
Phase II Study of the Antibody Drug Conjugate Trastuzumab-DM1 for the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2) -Positive Breast Cancer After Prior HER2-Directed Therapy [J].
Burris, Howard A., III ;
Rugo, Hope S. ;
Vukelja, Svetislava J. ;
Vogel, Charles L. ;
Borson, Rachel A. ;
Limentani, Steven ;
Tan-Chiu, Elizabeth ;
Krop, Ian E. ;
Michaelson, Richard A. ;
Girish, Sandhya ;
Amler, Lukas ;
Zheng, Maoxia ;
Chu, Yu-Waye ;
Klencke, Barbara ;
O'Shaughnessy, Joyce A. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04) :398-405
[5]
The transcriptional network for mesenchymal transformation of brain tumours [J].
Carro, Maria Stella ;
Lim, Wei Keat ;
Alvarez, Mariano Javier ;
Bollo, Robert J. ;
Zhao, Xudong ;
Snyder, Evan Y. ;
Sulman, Erik P. ;
Anne, Sandrine L. ;
Doetsch, Fiona ;
Colman, Howard ;
Lasorella, Anna ;
Aldape, Ken ;
Califano, Andrea ;
Iavarone, Antonio .
NATURE, 2010, 463 (7279) :318-U68
[6]
Genome-wide Functional Annotation of Dual-Specificity Protein- and Lipid-Binding Modules that Regulate Protein Interactions [J].
Chen, Yong ;
Sheng, Ren ;
Kaellberg, Morten ;
Silkov, Antonina ;
Tun, Moe P. ;
Bhardwaj, Nitin ;
Kurilova, Svetlana ;
Hall, Randy A. ;
Honig, Barry ;
Lu, Hui ;
Cho, Wonhwa .
MOLECULAR CELL, 2012, 46 (02) :226-237
[7]
Comprehensive genomic characterization defines human glioblastoma genes and core pathways [J].
Chin, L. ;
Meyerson, M. ;
Aldape, K. ;
Bigner, D. ;
Mikkelsen, T. ;
VandenBerg, S. ;
Kahn, A. ;
Penny, R. ;
Ferguson, M. L. ;
Gerhard, D. S. ;
Getz, G. ;
Brennan, C. ;
Taylor, B. S. ;
Winckler, W. ;
Park, P. ;
Ladanyi, M. ;
Hoadley, K. A. ;
Verhaak, R. G. W. ;
Hayes, D. N. ;
Spellman, Paul T. ;
Absher, D. ;
Weir, B. A. ;
Ding, L. ;
Wheeler, D. ;
Lawrence, M. S. ;
Cibulskis, K. ;
Mardis, E. ;
Zhang, Jinghui ;
Wilson, R. K. ;
Donehower, L. ;
Wheeler, D. A. ;
Purdom, E. ;
Wallis, J. ;
Laird, P. W. ;
Herman, J. G. ;
Schuebel, K. E. ;
Weisenberger, D. J. ;
Baylin, S. B. ;
Schultz, N. ;
Yao, Jun ;
Wiedemeyer, R. ;
Weinstein, J. ;
Sander, C. ;
Gibbs, R. A. ;
Gray, J. ;
Kucherlapati, R. ;
Lander, E. S. ;
Myers, R. M. ;
Perou, C. M. ;
McLendon, Roger .
NATURE, 2008, 455 (7216) :1061-1068
[8]
lumi:: a pipeline for processing Illumina microarray [J].
Du, Pan ;
Kibbe, Warren A. ;
Lin, Simon M. .
BIOINFORMATICS, 2008, 24 (13) :1547-1548
[9]
Activation of Rac1 by Src-dependent phosphorylation of Dock180Y1811 mediates PDGFRα-stimulated glioma tumorigenesis in mice and humans [J].
Feng, Haizhong ;
Hu, Bo ;
Liu, Kun-Wei ;
Li, Yanxin ;
Lu, Xinghua ;
Cheng, Tao ;
Yiin, Jia-Jean ;
Lu, Songjian ;
Keezer, Susan ;
Fenton, Tim ;
Furnari, Frank B. ;
Hamilton, Ronald L. ;
Vuori, Kristiina ;
Sarkaria, Jann N. ;
Nagane, Motoo ;
Nishikawa, Ryo ;
Cavenee, Webster K. ;
Cheng, Shi-Yuan .
JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (12) :4670-4684
[10]
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma [J].
Flaherty, Keith T. ;
Puzanov, Igor ;
Kim, Kevin B. ;
Ribas, Antoni ;
McArthur, Grant A. ;
Sosman, Jeffrey A. ;
O'Dwyer, Peter J. ;
Lee, Richard J. ;
Grippo, Joseph F. ;
Nolop, Keith ;
Chapman, Paul B. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (09) :809-819